Decoy Therapeutics Inc.
DCOY
$5.15
-$0.29-5.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.52M | -5.00M | -5.10M | -5.57M | -5.58M |
| Total Depreciation and Amortization | 7.10K | 4.40K | 4.40K | 4.40K | 4.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.73M | 130.50K | 167.70K | 229.70K | 273.70K |
| Change in Net Operating Assets | -1.05M | 436.60K | 788.10K | 982.80K | 772.30K |
| Cash from Operations | -4.83M | -4.43M | -4.14M | -4.35M | -4.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 764.70K | -200.00K | -- | -- | -- |
| Cash from Investing | 764.70K | -200.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -221.80K | -328.80K | -398.70K | -403.40K | -466.60K |
| Issuance of Common Stock | 12.59M | 6.52M | 2.09M | 2.18M | 1.53M |
| Repurchase of Common Stock | -29.00K | -29.00K | -29.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.34M | 6.16M | 1.67M | 1.78M | 1.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.28M | 1.53M | -2.48M | -2.57M | -3.47M |